Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Osteoprotegerin, Fibroblast Growth Factor 23 and Vitamin D3 Levels in Male Patients With Hypogonadism

NCT02062307 is registered in ClinicalTrials.gov with Gulhane School of Medicine as lead sponsor.

NCT NCT02062307
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02062307 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Osteoprotegerin, Fibroblast Growth Factor 23 and Vitamin D3 Levels in Male Patients With Hypogonadism
Lead sponsor
Gulhane School of Medicine
Phase
Observational
Overall status
Completed
Start date
August 31, 2012
Completion date
August 31, 2013
Enrollment
92 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endothelial dysfunction, hypogonadotropic hypogonadism, insulin resistance